SEC Probe Nets Another Suspect In Connetics Case

Law360, New York (May 25, 2006, 12:00 AM EDT) -- Hoping to add another defendant to the roster, The U.S. Securities & Exchange Commission is seeking to amend its insider trading complaint against a Connetics Corp. executive to include a former neighbor after both allegedly traded on non-public information related to the company’s acne drug, Velac Gel.

On Wednesday, the SEC filed a motion to add Victor Zak as a defendant in the lawsuit, two months after regulators charged Alexander Yaroshinsky, Connetics' vice president of biostatistics and clinical operations, with engaging in improper trading.

The two...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.